Recent reports suggest the presence of an auto-aggressive CD8 T cell type in non-alcoholic steatohepatitis (NASH) and liver hepatocellular carcinoma (HCC, liver cancer), which displays markers for exhaustion, tissue residency, and effector function. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.